![]() |
|
|
Vol. 280, Issue 2, 638-649, 1997
Division of Toxicology, Leiden/Amsterdam Center for Drug Research,
Leiden University, 2300 RA Leiden, The Netherlands
Cisplatin-induced nephrotoxicity was studied in porcine proximal
tubular cells, focusing on the relationship between mitochondrial damage, reactive oxygen species (ROS) and cell death. Cisplatin specifically affected mitochondrial functions: complexes I to IV of the
respiratory chain were inhibited 15 to 55% after 20 min of incubation
with 50 to 500 µM, respectively. As a result, intracellular ATP was
decreased to 70%. The mitochondrial glutathione (reduced form)
(GSH)-regenerating enzyme GSH-reductase (GSH-Rd) activity was reduced
by 20%, which contributed to a 70% reduction of GSH levels and ROS
formation. The residual electron flow through the mitochondrial
respiratory chain was the source of ROS because additional inhibition
of the complexes I to IV reduced ROS formation. Because cisplatin
affects both GSH-Rd and complexes I to IV, cells were incubated with
N,N
-bis(2-chloroethyl)-N-nitrosourea (inhibitor of GSH-Rd) and
inhibitors of the different complexes. Only
N,N
-bis(2-chloroethyl)-N-nitrosourea with rotenone (complex I
inhibitor) induced ROS formation, which indicates that inhibition of
complex I and inhibition of the GSH-Rd is probably the cause of ROS
formation. However, the resulting ROS is not the cause of cell death
because diphenyl-p-phenylene-diamine and deferoxamine,
which completely prevented ROS, could not prevent cell death.
Similarly, the antioxidants did not completely prevent the decrease in
activity of complexes I to IV, ATP or GSH levels. In conclusion, ROS
formation does occur during cisplatin-induced toxicity, but it is not
the direct cause of cell death.
This article has been cited by other articles:
![]() |
S. Kopetz, D. P. Lesslie, N. A. Dallas, S. I. Park, M. Johnson, N. U. Parikh, M. P. Kim, J. L. Abbruzzese, L. M. Ellis, J. Chandra, et al. Synergistic Activity of the Src Family Kinase Inhibitor Dasatinib and Oxaliplatin in Colon Carcinoma Cells Is Mediated by Oxidative Stress Cancer Res., May 1, 2009; 69(9): 3842 - 3849. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kim, J.-W. Park, and K. M. Park Increased superoxide formation induced by irradiation preconditioning triggers kidney resistance to ischemia-reperfusion injury in mice Am J Physiol Renal Physiol, May 1, 2009; 296(5): F1202 - F1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Gao, J. L. Campian, M. Qian, X.-F. Sun, and J. W. Eaton Mitochondrial DNA Damage in Iron Overload J. Biol. Chem., February 20, 2009; 284(8): 4767 - 4775. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Jiang, C. Guo, M. R. Vasko, and M. R. Kelley Implications of Apurinic/Apyrimidinic Endonuclease in Reactive Oxygen Signaling Response after Cisplatin Treatment of Dorsal Root Ganglion Neurons Cancer Res., August 1, 2008; 68(15): 6425 - 6434. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. P. Shaik, E. K. Fifer, and G. Nowak Akt activation improves oxidative phosphorylation in renal proximal tubular cells following nephrotoxicant injury Am J Physiol Renal Physiol, February 1, 2008; 294(2): F423 - F432. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Prewett, D. S. Deevi, R. Bassi, F. Fan, L. M. Ellis, D. J. Hicklin, and J. R. Tonra Tumors Established with Cell Lines Selected for Oxaliplatin Resistance Respond to Oxaliplatin if Combined with Cetuximab Clin. Cancer Res., December 15, 2007; 13(24): 7432 - 7440. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L'Hoste, M. Poet, C. Duranton, R. Belfodil, H. e Barriere, I. Rubera, M. Tauc, C. Poujeol, J. Barhanin, and P. Poujeol Role of TASK2 in the Control of Apoptotic Volume Decrease in Proximal Kidney Cells J. Biol. Chem., December 14, 2007; 282(50): 36692 - 36703. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yang, V. Kaushal, S. V. Shah, and G. P. Kaushal Mcl-1 is downregulated in cisplatin-induced apoptosis, and proteasome inhibitors restore Mcl-1 and promote survival in renal tubular epithelial cells Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1710 - F1717. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li Campian, X. Gao, M. Qian, and J. W. Eaton Cytochrome c Oxidase Activity and Oxygen Tolerance J. Biol. Chem., April 27, 2007; 282(17): 12430 - 12438. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Erkan, P. Devarajan, and G. J. Schwartz Mitochondria Are the Major Targets in Albumin-Induced Apoptosis in Proximal Tubule Cells J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1199 - 1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Qian, M. Nishikawa, A. Md. Haque, M. Hirose, M. Mashimo, E. Sato, and M. Inoue Mitochondrial density determines the cellular sensitivity to cisplatin-induced cell death Am J Physiol Cell Physiol, December 1, 2005; 289(6): C1466 - C1475. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Seth, C. Yang, V. Kaushal, S. V. Shah, and G. P. Kaushal p53-dependent Caspase-2 Activation in Mitochondrial Release of Apoptosis-inducing Factor and Its Role in Renal Tubular Epithelial Cell Injury J. Biol. Chem., September 2, 2005; 280(35): 31230 - 31239. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Imamdi, M. de Graauw, and B. van de Water Protein Kinase C Mediates Cisplatin-Induced Loss of Adherens Junctions Followed by Apoptosis of Renal Proximal Tubular Epithelial Cells J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 892 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Campian, M. Qian, X. Gao, and J. W. Eaton Oxygen Tolerance and Coupling of Mitochondrial Electron Transport J. Biol. Chem., November 5, 2004; 279(45): 46580 - 46587. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tsuruya, M. Tokumoto, T. Ninomiya, M. Hirakawa, K. Masutani, M. Taniguchi, K. Fukuda, H. Kanai, H. Hirakata, and M. Iida Antioxidant ameliorates cisplatin-induced renal tubular cell death through inhibition of death receptor-mediated pathways Am J Physiol Renal Physiol, August 1, 2003; 285(2): F208 - F218. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Satoh, N. Kashihara, S. Fujimoto, H. Horike, T. Tokura, T. Namikoshi, T. Sasaki, and H. Makino A Novel Free Radical Scavenger, Edarabone, Protects Against Cisplatin-Induced Acute Renal Damage in Vitro and in Vivo J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1183 - 1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Cummings and R. G. Schnellmann Cisplatin-Induced Renal Cell Apoptosis: Caspase 3-Dependent and -Independent Pathways J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 8 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Davis, H. S. Nick, and A. Agarwal Manganese Superoxide Dismutase Attenuates Cisplatin-Induced Renal Injury: Importance of Superoxide J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2683 - 2690. [Abstract] [Full Text] [PDF] |
||||